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Using the Immunochip for genotyping, we identified 39 non-human leukocyte antigen (non-HLA) loci associated
to celiac disease (CeD), an immune-mediated disease with a worldwide frequency of∼1%. The most significant
non-HLA signal mapped to the intronic region of 70 kb in the LPP gene. Our aim was to fine map and identify
possible functional variants in the LPP locus. We performed a meta-analysis in a cohort of 25 169 individuals
from six different populations previously genotyped using Immunochip. Imputation using data from the
Genome of the Netherlands and 1000 Genomes projects, followed by meta-analysis, confirmed the strong
association signal on the LPP locus (rs2030519, P 5 1.79 3 10249), without any novel associations. The condi-
tional analysis on this top SNP-indicated association to a single common haplotype. By performing haplotype
analyses in each population separately, as well as in a combined group of the four populations that reach the
significant threshold after correction (P < 0.008), we narrowed down the CeD-associated region from 70 to
2.8 kb (P 5 1.35 3 10244). By intersecting regulatory data from the ENCODE project, we found a functional
SNP, rs4686484 (P 5 3.12 3 10249), that maps to several B-cell enhancer elements and a highly conserved
region. This SNP was also predicted to change the binding motif of the transcription factors IRF4, IRF11,
Nkx2.7 and Nkx2.9, suggesting its role in transcriptional regulation. We later found significantly low levels of
LPP mRNA in CeD biopsies compared with controls, thus our results suggest that rs4686484 is the functional
variant in this locus, while LPP expression is decreased in CeD.
†These authors contributed equally.
‡Present address: Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
∗To whom correspondence should be addressed at: Department of Genetics, University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen,
The Netherlands. Email: c.wijmenga@umcg.nl
# The Author 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/),
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Human Molecular Genetics, 2014, Vol. 23, No. 9 2481–2489
doi:10.1093/hmg/ddt619









roningen user on 03 February 2020
INTRODUCTION
In recent years, genome-wide association studies (GWAS) have
identified thousands of new susceptibility loci for common dis-
eases, including dozens for celiac disease (CeD) (1,2). CeD is an
immune-mediated disease triggered by gluten in the diet of
genetically susceptible individuals, and it is strongly correlated
with the presence of specific HLA-DQ isotypes, which are neces-
sary but not sufficient to lead to the disease (3). In a previous
GWAS, we identified 26 non-human leukocyte antigen (non-
HLA) loci with small effect size that explain part of the heritability
of CeD (4). Recently, we used the Immunochip (5) and discovered
13 additional susceptibility loci, as well as fine mapping.50% of
all 40 loci (6). In total, we reported 39 non-HLA susceptibility
loci, which together with the HLA locus, explain 50% of CeD
heritability (6). The strongest non-HLA association signal maps
to a 70 kb linkage disequilibrium (LD) block in intron 2 of the
LPP gene. Conditional analysis of this highly associated variant
revealed no other signals of association, indicating a single-
associated haplotype in this locus.
The LPP gene has also been reported to be associated with viti-
ligo (7), an autoimmune disease, in which the top SNP is located
in the same haplotype as the CeD top SNP (r2 ¼ 0.8 and
D′ ¼ 0.9). The LPP gene is involved in cell motility and cell–
cell adhesion, which is crucial to maintaining the barrier integ-
rity of epithelial monolayers, especially in the small intestine.
It might therefore play a role in the pathogenesis of CeD (8,9).
Our aim was to fine map the CeD-associated 70 kb intronic
region at the LPP locus and to identify possible functional
variants. We used data from six different CeD populations
(UK, Dutch, Polish, Spanish, Italian and Indian) genotyped on
the Immunochip array. Further, a haplotype analysis was per-
formed, followed by haplotype association testing in each popu-
lation separately. Finally, we intersected the fine-mapped region
with functional annotation data from the ENCODE project (10).
This allowed us to refine the 70 kb region of association to a
25-fold smaller region of 2.8 kb enriched with regulatory
elements, where we identified one SNP predicted to change
transcription-factor-binding motif.
RESULTS
Meta-analysis identified a single variant at LPP locus
In order to fine map the 70 kb LPP LD region, we performed a
meta-analysis on a large cohort of 25 169 individuals, who had
been genotyped by Immunochip (Table 1, Supplementary Mater-
ial, Table S1). The SNP with the highest association with CeD was
located within intron 2 of the LPP locus (rs2030519;P ¼ 1.76 ×
10249; OR¼ 0.75, 95% CI 0.72–0.78) (Fig. 1A and B), where the
minor allele G is more frequent in controls than in CeD cases, sug-
gesting that the allele has a protective effect. To check for possible
additional independent signals, we performed a conditional ana-
lysis on this top SNP, but did not uncover any novel significant
signals (Supplementary Material, Fig. S1), indicating association
to a single, common haplotype.
Imputation confirmed the meta-analysis results
In order to test whether any non-genotyped variants were more
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Figure 1. Fine mapping of the LPP region. (A) Localization of the LPP gene on chromosome 3 and the LD region. (B) Meta-analysis of imputation and Immunochip
(iCHIP) results. Open circles are SNPs genotyped by the iCHIP, black dots represent SNPs imputed by GoNL and gray dots represent SNPs imputed by the 1000
Genomes Project (1kG). (C) SNPs in the fine-mapping region overlapping to ENCODE regulatory regions, including DNase I hypersensitive sites, histone modifica-
tions determined by ChIP-seq and transcription factor-binding site ChIP signals. Signal peaks are depicted as darker regions. Evolutionary conserved sites are also
shown. ∗14 SNPs that construct the core-haplotype. ∗∗7 SNPs in orange differentiate the risk from the non-risk haplotype. The functional candidate SNP rs4686484 is
depicted in red. The top meta-analysis SNP is in blue. (D) Sequencing of the functional candidate SNP predicted to change the binding site of the shown transcription
factors. Prot, protective; Ref, reference.
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genotypes using two different reference panels [1000 Genomes
Project and Genome of the Netherlands (GoNL)]. This analysis
resulted in an additional 397 SNPs (254 SNPs from the 1000
Genomes project data, 110 SNPs from the GoNL study, with
33 SNPs identified by both). We then performed a meta-analysis
on both the known, as well as the imputed, SNPs. This confirmed
that SNP rs2030519 was the strongest CeD-associated SNP in
the LPP locus (P ¼ 1.79 × 10249, OR ¼ 0.75, 95% CI 0.72–
0.78) in this region (Fig. 1B).
Association analysis in different populations indicated
different top SNPs
Since the meta-analysis identified rs2030519 as the most strong-
ly associated SNP, we tested whether rs2030519 was also the top
SNP in the six separate populations. The top SNP was confirmed
as the strongest associated SNP only in the UK population (the
largest cohort) (P ¼ 4.56 × 10238, OR ¼ 0.74, 95% CI 0.70–
0.77), whereas in the other five populations, different top SNPs
were identified (Table 1). In the Italian population, the top
SNP was rs9834159 (P ¼ 2.11 × 1027, OR ¼ 0.74, 95% CI
0.67–0.83), and in the Dutch and Spanish cohorts the top SNP
was rs60946162 (P ¼ 0.002, OR ¼ 0.8, 95% CI 0.73–0.93
and P ¼ 0.0004, OR ¼ 0.78, 95% CI 0.67–0.89, respectively).
The top SNPs in the Polish cohort (rs2103025; P ¼ 0.004,
OR ¼ 1.4, 95% CI 1.12–1.85) and in the Indian cohort
(rs11923721; P ¼ 0.02, OR ¼ 1.4, 95% CI 1.05–2.58)
showed association in opposite directions (Table 1) to the top
SNPs in the other four cohorts (UK, Italy, Netherlands and
Spain). These results suggest that there could be population-
specific, CeD-associated alleles.
Haplotype analysis suggested a common CeD-associated
haplotype
The existence of different CeD-associated top SNPs in differ-
ent populations may suggest that these SNPs could be
tagging a common functional variant on a common haplotype.
We therefore included all the genotyped SNPs within a 250 kb
window around the top SNP (rs2030519) from the
meta-analysis, and generated haplotypes in populations that
showed significant P-value with rs2030519 after a Bonferroni
correction for the six populations (P , 0.008). Next, we
tested the association of haplotypes with CeD using logistic re-
gression in the separate populations. The Indian and Polish
cohort were excluded from haplotype association analysis
(Supplementary Material, Table S3). We therefore performed
the haplotype association test in a meta-analysis of the four
remaining populations together (UK, Italy, Netherlands and
Spain). The biggest haplotype size (53.7 kb) was found in the
Dutch cohort (Table 2) and the smallest haplotype (3.1 kb,
Table 2) was found in the UK population, which was the
largest cohort (Supplementary Material, Table S1). By
looking at the most strongly associated haplotype in each of
the European populations, we identified a core haplotype of
4.1 kb containing 14 SNPs (Table 2 and Supplementary Mater-
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Seven SNPs differentiate risk and non-risk haplotypes
In order to see whether differences in the risk and protective hap-
lotypes across populations could reduce the size of this region,
we performed a haplotype logistic regression using the 14
SNPs (Table 3) in each population separately, as well as in all
four populations together (Table 3). By comparing the haplo-
types obtained, we found a common, associated haplotype
present in all the populations (Table 3). Seven of the 14 SNPs
showed minor alleles present in the protective haplotype, but
absent in the risk haplotype (Table 3). This approach reduced
the core haplotype down to a 2.8 kb region (chr3: 188117070–
188119901, NCBI build 37) and suggests that this region
might well harbor the causative variant for CeD (Fig. 1C).
Annotation of established functional elements in the core
haplotype region
To investigate whether the seven core-haplotype SNPs are
located within known functional elements, they were subjected
to HaploReg. The 2.8 kb region contained open chromatin
regions, as identified in 19 cell lines of the ENCODE Project
cell line panel (Fig. 1C and Supplementary Material,
Table S5). Of the seven SNPs, six (rs6790260, rs6444285,
rs4686483, rs4686484, rs6778720 and rs2030520) mapped to
regions annotated with histone modifications H3K27ac,
H3K4m1, H3k4 m2, H2A.Z and EZH2 identified in B- and
T-cells (Fig. 1C and Supplementary Material, Table S5). Inter-
estingly, SNP rs4686484 (P ¼ 3.12 × 10249), which is in high
LD with the top-meta SNP, rs2030519 (r2 ≥ 0.9 and D′ ¼ 1),
maps to DNase hypersensitive sites in multiple cell lines (includ-
ing B- and T-cells). In addition, it maps to overlapping DNA
fragments that were individually isolated by chromatin immuno-
precipitation (ChIP) using antibodies against BATF and PU.1
(Fig. 1C and Supplementary Material, Table S5). Hence, SNP
rs4686484 is highly conserved (Fig. 1C, Supplementary Mater-
ial, Table S5) and HaploReg suggested that this SNP changes the
consensus-binding motif of the transcription factors IRF4,
IRF11, Nkx2.7 and Nkx2.9 (Fig. 1D, Supplementary Material,
Table S5).
In order to test whether the SNP rs4686484 can be prioritized
as the only candidate SNP without performing haplotype ana-
lysis, we subjected 174 SNPs present in the original 70 kb
region to HaploReg annotation (Supplementary Material,
Fig. S4). We found 12 SNPs in high LD with rs4686484 (r2 ≥
0.7 andD′ ¼ 1) overlapping with regulatory elements character-
ized by open chromatin, histone modification and transcription
factor binding. However, it is not clear which of these 12 SNPs
are functionally involved in CeD pathogenesis. Therefore, the
fine mapping by haplotype analysis helped us to prioritize the
most likely functional SNP even though the associated region
contained more than one SNP with similar regulatory potential.
Sanger sequencing to identify novel variants
In order to test whether the highly conserved regulatory region
contained novel variants in LD with SNP rs4686484, we
sequenced 391 bp around this functional SNP (chr3:
188118290–188118680, NCBI build 37) in 210 Dutch indivi-
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novel variants in the region, which was in concordance with
GoNL data (11). Although two SNPs (rs147428170 and
rs148483836) are located in this region (according to the 1000
Genomes Project), we were not able to confirm them in the
210 individuals we sequenced, probably because these two
SNPs are very rare (minor allele frequency, MAF, 0.001) in
the CEU population. We therefore consider SNP rs4686484 to
be the main functional candidate (Supplementary Material,
Table S6).
Low expression of the LPP gene in biopsies from
CeD patients
In order to test whether LPP gene levels are affected in the CeD
status, microarray expression analysis was performed on 25 duo-
denal biopsies (12 celiac patients with villous atrophy and 13
healthy controls) (Supplementary Material, Methods). This
showed a lower expression of the LPP gene in biopsies of
celiac patients with villous atrophy (Marsh III stage) compared
with healthy controls (Supplementary Material, Fig. S3).
These results suggestLPP is a causative gene in the pathogenesis
of CeD.
DISCUSSION
We aimed to refine a 70 kb LD region of theLPP gene, previous-
ly reported as the strongest non-HLA-associated locus in CeD,
and to identify possible functional variants. We analyzed geno-
type data obtained with Immunochip in six-independent popula-
tions in this region (6). A meta-analysis on the six sets of
genotyped and imputed data confirmed that the strongest associ-
ation was to the SNP rs2030519 (P ¼ 1.79 × 10249) located in
intron 2 of the LPP locus (Fig. 1A and B). Subsequent condition-
al analysis on this SNP indicated no other independent associa-
tions and suggested the presence of a single, common risk
haplotype in this locus (Supplementary Material, Fig. S1).
It has been suggested that disease etiology is common
between populations, but that risk variants are often population
specific (12). Here, we performed a population-specific associ-
ation analysis to test the genetic heterogeneity between six popu-
lations. Except for the UK population, their top SNPs differed
from the meta-analysis top SNP (Table 1). In addition, except
for the Polish top SNP, the top SNPs of the other populations
were in LD with the meta-analysis top SNP (Table 1), suggesting
a common-associated haplotype in these populations.
Haplotype analysis using different populations has been
shown to be a suitable strategy for fine-mapping associated
regions (13). Since haplotypes characterize the exact organiza-
tion of alleles along the chromosome (14), more information
can be incorporated into the association tests by constructing
haplotype blocks from SNPs (15). Accordingly, in this study,
we were able to find a core haplotype of 4.1 kb by comparing
the most strongly-associated haplotype per population in four
Caucasian cohorts, which indicated a common associated haplo-
type between these populations (Fig. 1C, Table 2). In addition,
we observed that the sample size of the study cohort is very im-
portant to narrow down the associated regions. By analyzing
only the two largest populations (UK and Italy), we found a
haplotype with a more similar size of 4.8 kb than when we
investigated all the populations together (Supplementary Mater-
ial, Fig S2). However, only by adding the other populations, we
were able to compare risk and protective haplotypes, and finally
pinpoint seven SNPs that differentiate the risk haplotype from
the non-risk haplotype across different populations (Fig. 1C,
Table 3). This helped us to refine the associated region down
to 2.8 kb, where a functional variant might be located.
It has been shown that there is an enrichment of regulatory ele-
ments from the ENCODE project overlapping SNPs identified
by GWAS (10,16). To prioritize SNPs in the 2.8 kb region that
could have a functional effect, we intersected all seven SNPs
in the 2.8 kb region with regulatory information available from
the ENCODE Project (10). In the end, we were able to identify
six out of seven SNPs that mapped to a regulatory region,
either to DNase hypersensitive sites or regions with enhancers
histone modifications (Fig. 1C, Supplementary Material,
Table S4). One SNP, rs4686484, directly overlapped these two
regulatory sites and also mapped to transcription-factor-binding
sites (Fig. 1C). The G allele at rs4686484 was predicted to inter-
fere with the consensus motives of transcription factors IRF4,
IRF11, Nfx2.7 and Nfx2.9 (Fig. 1D). Interestingly, IRF4 has
been described as interacting with PU.1 (17), and since the G
allele of the functional SNP interferes with IRF4 binding, it is
possible that this SNP could affect IRF4-mediated PU.1
binding. Whether this alteration would increase or decrease the
expression of LPP remains to be tested. Moreover, the IRF4
gene was also reported to be associated with CeD (6), and it
could be that it somehow interacts with the LPP gene. To inves-
tigate this, we used Genenetwork (www.genenetwork.nl) and
DAVID (18); however, we did not find any shared pathways
between LPP and IRF4 (results not shown).
The lack of any novel variants on sequencing, as well as the
many overlapping layers of regulatory information within this
highly conserved regulatory region, confirmed rs4686484 as
the most likely functional SNP (Supplementary Material,
Table S6). However, we did not find any eQTL effect for SNP
rs4686484 in a peripheral blood dataset of 1240 samples (19).
We were therefore unable to establish a causal link between
the prioritized functional SNP and the LPP gene. Nonetheless,
microarray analysis in duodenal biopsies showed that the LPP
gene is down-regulated in severe CeD cases (villous atrophy,
Marsh III) compared with healthy individuals (Supplementary
Material, Fig. S3). We examined the expression level of LPP
in biopsies from individuals genotyped for the rs4686484 SNP,
but found no significant difference, most likely due to our very
limited sample size (n ¼ 25) (results not shown). Nevertheless,
this result is in agreement with a previous study that also
showed lower expression of the LPP gene in biopsies of CeD
patients (20), suggesting thatLPP is the most plausible causative
gene in this locus.
The fact that many regulatory elements in B-cells from the
ENCODE project overlap with the fine-mapped region
(Fig. 1C, Supplementary Material, Table S5) suggests that our
functional SNP may impact gene expression in B-cells.
Although CeD is known to be mainly a T-cell disorder, the
role of B-cells in the pathogenesis of CeD is being increasingly
recognized (21,22). It has been suggested that B-cells, in com-
bination with the enzyme transglutaminase 2, can present
gluten peptides to gluten reactive T-cells (22). Our data
suggest that B-cells are an important cell type for performing
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functional assays to better understand the role of theLPP locus in
CeD pathogenesis.
Since the prioritized SNP rs4686484 has a regulatory func-
tion, it may affect other genes outside of the LD block as well.
In this context, the BCL6 gene, located 658.7 kb away from
the candidate SNP, is a plausible candidate. Recently, a
meta-analysis for allergic sensitization identified an SNP
(rs9865818) located in the LPP gene, and in LD with our candi-
date SNP rs4686484 (r2 ¼ 0.75, D′ ¼ 0.93), that showed a
cis-eQTL effect specifically for B-cells in the BCL6 gene (23).
This suggests that it is still possible that the SNP rs4686484, or
an SNP in the same haplotype, can act by regulating BCL6 spe-
cifically in B-cells. Additionally, to support this idea, it is known
that IRF4 and BCL6 have a very close interaction. We therefore
analyzed the expression data ofBCL6 in biopsies similar toLPP,
but found no difference between CeD and healthy control biop-
sies (Supplementary Material, Fig S5). This finding suggests that
LPP is a candidate gene. However, we do not have any conclu-
sive evidence that links our possible causative SNP with the
LPP gene. Hence, more eQTL studies in B-cell-specific datasets
are necessary to establish a true causal gene.
In summary, we were able to narrow down an intronic region
strongly associated with CeD from 70 to 2.8 kb. By integrating
data from the ENCODE project with our findings, we identified
six SNPs that overlap regulatory sites (Fig. 1C), with one,
rs4686484, having a possible biological function. In addition,
gene expression data from patient biopsies suggested that the
LPP gene might be involved in the pathogenesis of CeD.




The CeD study population (12 513 patients and 12 656 controls)
included the samples described previously (6), with additional
samples in each population that had since become available
(Supplementary Material, Table S1). Affected individuals
were diagnosed as patients with CeD according to standard clin-
ical, serological and histo-pathological criteria, including a
small intestinal biopsy (24). DNA samples were isolated from
blood, lympho-blastoid cell lines or saliva, as indicated by
Trynka et al. (6). The details of the SNP probes present on the
Immunochip array, and of the genotyping and quality control
filters, have been reported previously (6). All the subjects
sampled for this project provided informed consent, and the
study was approved by the ethics committees or institutional
review boards of the hospitals where the samples were collected.
Association analyses
A meta-analysis was performed in the 70 kb LPP LD region
(chr3: 188069360–188139629, NCBI build 37) using PLINK
(25). Gender and the country of origin were included as covari-
ates. PLINK was also used for a stepwise, conditional logistic
regression of the most associated SNPs showing the highest
meta-analysis association P-value. In order to assess the associ-
ation per population, we performed a logistic regression on each
population separately, using gender as a covariate.
Imputation
SNPs were imputed across the LPP LD region using data from
the 1000 Genomes Project (26) and from the GoNL (11) as ref-
erence panels. Before imputation, the data were filtered for
SNPs with an MAF .0.01 and deviations from Hardy–
Weinberg equilibrium in controls (P . 0.0001), and subse-
quently aligned to the forward strand. The data were analyzed
in batches comprising 500 samples and 2000 SNPs, with an
overlap of 500 SNPs. Phasing was performed using MACH
1.0.18 (27) applying 20 rounds of 200 states. We used
MOLGENIS compute (28) imputation pipeline to generate our
scripts and monitor the imputation. IMPUTE2 (29) was used
in both reference panels, applying its default options. Finally,
a meta-analysis on all the cohorts together was performed, as
described above.
Haplotype analysis
Haplotype analyses were performed using PLINK v1.7 (25),
where haplotype blocks were generated within a 250 kb
window harboring the most significant SNP from the
meta-analysis. Next, a Bonferroni correction was performed
for the six populations tested and only the populations that had
the top meta-analysis SNP with significant P-value (0.008)
were included for further analysis. Afterwards, a haplotype
logistic regression analysis in each population was performed.
In order to see differences in the risk versus non-risk haplotypes,
SNPs located in the core haplotype (an overlapping, shared
haplotype region in all populations) were used to perform a
haplotype association test per population.
Functional annotation of variants
The regulatory regions overlapping with the identified SNPs and
proxies (r2 ≥ 0.9, 1000 Genomes project-CEU), and present in
the fine-mapped haplotype, were annotated using HaploRegv2
(30) default settings. HaploReg takes the SNPs on the haplotype
block, and using LD information from the 1000 Genomes
Project, intersects these SNPs with functional regions identified
by the ENCODE project (10). In addition, it predicts the effects
of an SNP in a regulatory region based on a library of position-
weighted matrices collected from JASPER (31), TRANSFAC
(32) and protein-binding microarray experiments (33–35). Hap-
loReg v2 also provides annotation of mammalian conservation
based on GERP (36) and Si-phy (37) algorithms. UCSC
Genome Browser was used to look for intersections between
SNPs and regulatory elements from the most recent data of the
ENCODE project (10).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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